Being overweight or obese may put adults with diabetes at greater risk of dying from cancer than their diabetes-free counterparts, particularly for obesity-related cancers such as those arising from the bowel, kidney, and pancreas in men and women, and from the breast and endometrium (lining of the uterus) in women.
New research presented at this year's European Congress on Obesity (ECO) in Vienna, Austria (23-26) May shows chewing gum while walking increases heart rate and energy expenditure.
A study of more than 18,000 patients in Denmark, presented at this year’s European Congress on Obesity in Vienna, Austria (23-26), shows that patients admitted to hospital for treatment for any infectious disease are around twice as likely to survive if they are overweight or obese.
New research from various cities in the world presented at this year's European Congress on Obesity in Vienna, Austria (23-26 May) demonstrate that if current trends continue, almost a quarter (22%) of the people in the world will be obese by 2045 (up from 14% in 2017), and one in eight (12%) will have type 2 diabetes (up from 9% in 2017).
A new review of the latest evidence on sugar-sweetened beverages (SSBs)– which includes 30 new studies published between 2013 and 2015 (and none of them industry sponsored) – concludes that SSB consumption is associated with overweight and obesity, and that countries that have not already done so should take action to reduce the consumption of the so-called ‘empty calories’ that these drinks contain.
The UK's first National Health Service (NHS) service to provide a new, non-surgical, reversible weight loss device for people who have both poorly controlled type 2 diabetes and obesity is safe and effective and should be rolled out across the NHS, according to new research being presented at this year's European Association for the Study of Diabetes (EASD) Annual Meeting in Lisbon, Portugal (11-15 September).
New research presented at this year’s European Congress on Obesity (ECO) in Porto, Portugal (17-20 May) shows that a swallowable gastic balloon – that can be inserted without endoscopy or anaesthesia – is a safe and effective way to induce substantial weight loss. The study is by Dr Roberta Ienca, Sapienza University of Rome, Italy, and colleagues.
